Bye-Bye, DNA – Hello GSK (and others)

via The Outline author Paris Martineau, comes this tale of opt-in/opt-out, GlaxoSmithKline 23andMe. and of course, The Goods – , your DNA. Which results in a nagging question: Why would I (or you for that matter), agree to hand over my uniquely identifying DNA data to a commercial enterprise to use as they see fit (much less safeguard)? Oh, and a couple of other questions: Do you trust a big-pharma corporation with your own personal Map of Life? What about the future use of that data, once it’s in the slipstream of artificially intelligent genetic-testing-reliant health insurance companies? Food for Thought or just Paranoia? You be the judge; after all, it’s your DNA, right?

“In short, most — if not all — of the information 23andMe has on its users has probably been shared with someone that isn’t 23andMe itself, and money might have even changed hands. Which is all perfectly within the company’s rights to do, since they agreed to it (probably blindly) when they signed up.” – via The Outline author Paris Martineau in the well crafted post ‘How To Sign Away The Rights To Your DNA



*** This is a Security Bloggers Network syndicated blog from Infosecurity.US authored by Marc Handelman. Read the original post at: https://www.infosecurity.us/blog/2018/7/27/bye-bye-dna-hello-gsk